“The majority of treatments out there don't allow the maintenance of ejaculation after surgery, whereas here, we're at 90% for the small glands…[and at] 81% [for] the men who had prostates above 80 grams,” says Naeem Bhojani, MD, FRCSC.
In this video, Naeem Bhojani, MD, FRCSC, and David-Dan Nguyen discuss the background and findings of the study, “WATER vs WATER II: Three Year Comparison of Aquablation Therapy for Benign Prostatic Hyperplasia,” presented at the 2021 American Urological Association Annual Meeting. Bhojani is a urologist at CHUM Research Centre and an associate professor in the departments of surgery and social and preventative medicine at the University of Montreal, and Nguyen is a medical student at McGill University, Montreal, Quebec, Canada.
Academic, private practice urologists collaborate to change BPH reimbursement
April 1st 2024"We really aimed to affect 3 different contraindications and instead achieved retirement of the entire policy, which, we think, really opens up this wonderful technology to literally hundreds of thousands more patients across the country," says Arpeet Shah, MD.
Fertility preservation in patients with testicular cancer
March 8th 2024"Full discussion of the various fertility preservation options and an understanding of the fertility implications of the various treatment modalities must be understood by patients for them to make optimal decisions for their reproductive futures," write the authors.